Details
| Original language | English |
|---|---|
| Title of host publication | GDPR and Biobanking |
| Place of Publication | Cham |
| Pages | 277-290 |
| Number of pages | 14 |
| ISBN (electronic) | 978-3-030-49388-2 |
| Publication status | Published - 6 Jan 2021 |
Publication series
| Name | Law, Governance and Technology Series |
|---|---|
| Volume | 43 |
| ISSN (Print) | 2352-1902 |
| ISSN (electronic) | 2352-1910 |
Abstract
Biobanking in Germany is currently not subject to sui generis regulation. Instead, a plethora of norms from differing areas of law form the bundle of regulation that applies to biobanking. The exact shape and extent of the bundle depends on the exact configuration of the biobank. In the context of data protection, the rather fragmented nature of the regulation is to a certain extent alleviated by the direct impact of the EU General Data Protection Regulation (GDPR). In particular, the federalized system of data protection in Germany is simplified by an overarching set of norms that apply equally across the board. Whilst this is a welcome systematization of this part of the regulation of biobanking in Germany, the exact nature of the implementation of the Regulation raises novel issues in its own right. In this paper, I will outline the fragmented nature of biobank regulation in Germany, illustrate the issues on the basis of Germany’s population biobank NaKo and then discuss some of the more significant issues raised by the GDPR in the context of biobanking.
ASJC Scopus subject areas
- Social Sciences(all)
- Law
- Computer Science(all)
- Artificial Intelligence
- Computer Science(all)
- Computer Science Applications
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
GDPR and Biobanking. Cham, 2021. p. 277-290 (Law, Governance and Technology Series; Vol. 43).
Research output: Chapter in book/report/conference proceeding › Contribution to book/anthology › Research › peer review
}
TY - CHAP
T1 - The Regulation of Biobanking in Germany
AU - Hoppe, Nils
PY - 2021/1/6
Y1 - 2021/1/6
N2 - Biobanking in Germany is currently not subject to sui generis regulation. Instead, a plethora of norms from differing areas of law form the bundle of regulation that applies to biobanking. The exact shape and extent of the bundle depends on the exact configuration of the biobank. In the context of data protection, the rather fragmented nature of the regulation is to a certain extent alleviated by the direct impact of the EU General Data Protection Regulation (GDPR). In particular, the federalized system of data protection in Germany is simplified by an overarching set of norms that apply equally across the board. Whilst this is a welcome systematization of this part of the regulation of biobanking in Germany, the exact nature of the implementation of the Regulation raises novel issues in its own right. In this paper, I will outline the fragmented nature of biobank regulation in Germany, illustrate the issues on the basis of Germany’s population biobank NaKo and then discuss some of the more significant issues raised by the GDPR in the context of biobanking.
AB - Biobanking in Germany is currently not subject to sui generis regulation. Instead, a plethora of norms from differing areas of law form the bundle of regulation that applies to biobanking. The exact shape and extent of the bundle depends on the exact configuration of the biobank. In the context of data protection, the rather fragmented nature of the regulation is to a certain extent alleviated by the direct impact of the EU General Data Protection Regulation (GDPR). In particular, the federalized system of data protection in Germany is simplified by an overarching set of norms that apply equally across the board. Whilst this is a welcome systematization of this part of the regulation of biobanking in Germany, the exact nature of the implementation of the Regulation raises novel issues in its own right. In this paper, I will outline the fragmented nature of biobank regulation in Germany, illustrate the issues on the basis of Germany’s population biobank NaKo and then discuss some of the more significant issues raised by the GDPR in the context of biobanking.
UR - http://www.scopus.com/inward/record.url?scp=85120420714&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-49388-2_15
DO - 10.1007/978-3-030-49388-2_15
M3 - Contribution to book/anthology
SN - 978-3-030-49387-5
T3 - Law, Governance and Technology Series
SP - 277
EP - 290
BT - GDPR and Biobanking
CY - Cham
ER -